Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02287701 · ClinicalTrials.gov registry record · NA
Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02287701: Completed NA study, sponsored by NYU Langone Health.
NCT02287701 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02287701, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The overarching goal of this project is to explore whether associations exist between metrics obtained from PET/MRI incorporating advanced MRI sequences and features of bladder cancer, including grade, stage, and treatment response.
Primary Outcome
The tumor SUV value obtained approximately one hour following 18-fluorodeoxyglucose administration will be measured.
Interventions
- PROCEDURE PET/MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-09 |
| Phase | NA |
What the finished NCT02287701 record still lists
NCT02287701 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which PET/MRI is the first listed.
NCT02287701 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02287701 about?
NCT02287701 is a clinical study titled "Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization". The overarching goal of this project is to explore whether associations exist between metrics obtained from PET/MRI incorporating advanced MRI sequences and features of bladder cancer, including grade, stage, and treatment response.
What is the current status of trial NCT02287701?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2014-05. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02287701?
The interventions under investigation include: PET/MRI (PROCEDURE).
Who is sponsoring clinical trial NCT02287701?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02287701's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia